---
document_datetime: 2025-09-26 15:06:47
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/hizentra-epar-all-authorised-presentations_en.pdf
document_name: hizentra-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.790409
conversion_datetime: 2025-12-22 00:05:16.616803
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form              | Route of Administration   | Immediate Packaging                    | Content (concentration)   | Pack size                       |
|------------------|-------------------|------------|----------------------------------|---------------------------|----------------------------------------|---------------------------|---------------------------------|
| EU/1/11/687/001  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | vial (glass)                           | 5 ml                      | 1 vial                          |
| EU/1/11/687/002  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | vial (glass)                           | 5 ml                      | 10 vials                        |
| EU/1/11/687/003  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | vial (glass)                           | 5 ml                      | 20 vials                        |
| EU/1/11/687/004  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | vial (glass)                           | 10 ml                     | 1 vial                          |
| EU/1/11/687/005  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | vial (glass)                           | 10 ml                     | 10 vials                        |
| EU/1/11/687/006  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | vial (glass)                           | 10 ml                     | 20 vials                        |
| EU/1/11/687/010  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | vial (glass)                           | 20 ml                     | 1 vial                          |
| EU/1/11/687/011  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | vial (glass)                           | 20 ml                     | 10 vials                        |
| EU/1/11/687/012  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | vial (glass)                           | 20 ml                     | 20 vials                        |
| EU/1/11/687/013  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | vial (glass)                           | 50 ml                     | 1 vial                          |
| EU/1/11/687/014  | Hizentra          | 200 mg/ml  | Solution for                     | Subcutaneous use          | vial (glass)                           | 50 ml                     | 10 vials                        |
| EU/1/11/687/015  | Hizentra          | 200 mg/ml  | injection Solution for injection | Subcutaneous use          | pre-filled syringe (polymer)           | 5 ml                      | 1 pre-filled syringe            |
| EU/1/11/687/016  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | pre-filled syringe (polymer)           | 5 ml                      | 10 pre-filled syringes          |
| EU/1/11/687/017  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | pre-filled syringe (polymer)           | 10 ml                     | 1 pre-filled syringe            |
| EU/1/11/687/018  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | pre-filled syringe (polymer)           | 10 ml                     | 10 pre-filled syringes          |
| EU/1/11/687/019  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | pre-filled syringe (polymer)           | 20 ml                     | 1 pre-filled syringe            |
| EU/1/11/687/020  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | pre-filled syringe (polymer)           | 20 ml                     | 10 pre-filled syringes          |
| EU/1/11/687/021  | Hizentra          | 200 mg/ml  | Solution for                     | Subcutaneous use          | pre-filled syringe                     | 10 ml                     | 20 pre-filled                   |
| EU/1/11/687/022  | Hizentra          | 200 mg/ml  | injection Solution for injection | Subcutaneous use          | (polymer) pre-filled syringe (polymer) | 20 ml                     | syringes 20 pre-filled syringes |
| EU/1/11/687/023  | Hizentra          | 200 mg/ml  | Solution for injection           | Subcutaneous use          | pre-filled syringe (polymer)           | 50 ml                     | 1 pre-filled syringe            |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging          | Content (concentration)   | Pack size              |
|------------------|-------------------|------------|------------------------|---------------------------|------------------------------|---------------------------|------------------------|
| EU/1/11/687/024  | Hizentra          | 200 mg/ml  | Solution for injection | Subcutaneous use          | pre-filled syringe (polymer) | 50 ml                     | 10 pre-filled syringes |